2
项与 Umbilical cord mesenchymal stem cell therapy (Alliancells Bioscience) 相关的临床试验Clinical Trial of Umbilical Mesenchymal Stem Cells Transplantation for Liver Cirrhosis-Phase I/II
Liver cirrhosis and subsequent liver failure are leading causes of morbidity and mortality worldwide. Alcohol abuse and viral hepatitis are the most common causes of cirrhosis. Novel therapies are necessary to prevent or block the process of the disease. In this current prospective cohort, the investigators plan to organize four hospitals to determine the safety and efficacy of intravenous administration of umbilical mesenchymal stem cells in the treatment of patients with liver cirrhosis in next three years.
Clinical Trial of Umbilical Cord-Derived Mesenchymal Stem Cells Transplantation for Rheumatoid Arthritis-Phase I/II
Rheumatoid arthritis is a chronic systemic disease, which is characterized by chronic inflammation in the synovial tissue. Rheumatoid arthritis will eventually result in the destruction of cartilage, bone and ligaments and joint deformity. The underlying hypothesis is that umbilical cord-derived mesenchymal stem cell (UC-MSCs) has anti-inflammatory effects and thus potentially alleviates the progression of rheumatoid arthritis. The study is to explore the safety and efficacy of UC-MSCs transplantation in treatment of rheumatoid arthritis.
100 项与 Umbilical cord mesenchymal stem cell therapy (Alliancells Bioscience) 相关的临床结果
100 项与 Umbilical cord mesenchymal stem cell therapy (Alliancells Bioscience) 相关的转化医学
100 项与 Umbilical cord mesenchymal stem cell therapy (Alliancells Bioscience) 相关的专利(医药)
100 项与 Umbilical cord mesenchymal stem cell therapy (Alliancells Bioscience) 相关的药物交易